Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B118d253b64d14d53a8b3a4996a3499ee> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B118d253b64d14d53a8b3a4996a3499ee NCIT_P378 "NCI" @default.
- B118d253b64d14d53a8b3a4996a3499ee type Axiom @default.
- B118d253b64d14d53a8b3a4996a3499ee annotatedProperty IAO_0000115 @default.
- B118d253b64d14d53a8b3a4996a3499ee annotatedSource NCIT_C156692 @default.
- B118d253b64d14d53a8b3a4996a3499ee annotatedTarget "A humanized immunoglobulin G1 (IgG1) monoclonal antibody directed against the immunosuppressive ligand programmed cell death-1 (PD-L1; cluster of differentiation 274; CD274), with potential immune checkpoint inhibitory and antineoplastic activities. Upon administration, benmelstobart specifically targets and binds to PD-L1, preventing the binding and subsequent activation of its receptor, programmed cell death 1 (PD-1; PDCD1; CD279; programmed death-1). This reverses T-cell inactivation caused by PD-L1/PD-1 signaling, increases T-cell expansion and enhances the cytotoxic T-lymphocyte (CTL)-mediated anti-tumor immune response against PD-L1-expressing tumor cells. PD-L1, a transmembrane protein expressed on activated T-cells, is overexpressed in some cancer types and plays a significant role in immune evasion by tumor cells." @default.